Abstract 4797: In vitro and in vivo effect of ARQ 531 on Trk family kinases von Yu, Yi, Schwartz, Gabi, Schamber, Pascal, Savage, Ron E., Eathiraj, Sudharshan, Hall, Terence, Schwartz, Brian

Volltext

Abstract 2943: In vivo combination of miransertib (ARQ 092) with anti-PD-1 antibody, trametinib, lapatinib, trastuzumab and paclitaxel von Yu, Yi, Hall, Terence, Eathiraj, Sudharshan, Savage, Ron E., Schwartz, Brian

Volltext

Abstract 1963: ARQ 531, a potent reversible BTK inhibitor, exhibits potent antitumor activity in ibrutinib-resistant diffuse large B-cell lymphoma von Eathiraj, Sudharshan, Yu, Yi, Savage, Ron, Woyach, Jennifer A., Reiff, Sean D., Johnson, Amy J., Schwartz, Brian

Volltext

Abstract CT035: A phase Ib study of miransertib (ARQ 092) in combination with anastrozole in patients with PIK3CA or AKT1 -mutant ER+ endometrial or ovarian cancer von Hyman, David, Bonafede, Michael, O'Cearbhaill, Roisin, Grisham, Rachel, Zamarin, Dmitriy, Tew, William, Aghajanian, Carol, Cadoo, Karen, Friedman, Claire, Savage, Ron E., Chai, Feng, Schwartz, Brian, Makker, Vicky

Volltext

A Phase 1 Dose Escalation Study of ARQ 531 in Selected Patients with Relapsed or Refractory Hematologic Malignancies von Woyach, Jennifer A., Flinn, Ian W., Stephens, Deborah M., Awan, Farrukh T., Rogers, Kerry A., Reiff, Sean D., Savage, Ron E., Eathiraj, Sudharshan, Szuszkiewicz, Lyndsey A., Tith, Kate, Byrd, John C.

Volltext

Abstract CT024: Results of a phase I dose escalation study of ARQ 751 in adult subjects with advanced solid tumors with AKT1, 2, 3 genetic alterations, activating PI3K mutations, P... von Pant, Shubham, Subbiah, Vivek, Rodon, Jordi, Janku, Filip, Hong, David, Karp, Daniel, Piha-Paul, Sarina, Tsimberidou, Apostolia M., Naing, Aung, Fu, Siqing, Savage, Ron E., Chai, Feng, Yu, Yi, Schwartz, Brian, Meric-Bernstam, Funda, Yap, Tim

Volltext

Dirty Martinis von SAVAGE, RON

Volltext

American Daredevil von Savage, Ron

Volltext

Abstract A230: Discovery and characterization of ARQ 092, an ATP-independent, potent and selective inhibitor of AKT kinases von Chan, Thomas C.K., Lapierre, Jean-Marc, Ashwell, Mark A., France, Dennis S., Chen, Chang-Rung, Cornell-Kennon, Susan, Bull, Cathy, Eathiraj, Sudhi, Palma, Rocio, Liu, Yanbin, Makhija, Sapna, Waghorne, Carol, Savage, Ron, Fujiwara, Kosaku

Volltext

Abstract 3571: Exploratory biomarker discovery for clinical development of ARQ 087, a potent pan-FGFR kinase inhibitor von Yu, Yi, Gu, Xiubin, Nakuci, Enkelada, Zhao, Xiaolan, Chang, Edward, Szwaya, Jeff, Castro, Jenn, Cousens, Laura, Bull, Cathy, Wang, Yunxia, Savage, Ron, Waghorne, Carol, Chen, Chang-Rung, France, Dennis S., Clark, Edwin, Chan, Thomas C.K.

Volltext

Abstract 3905: Synthesis and structure activity relationship of substituted N,6-diphenyl-5,6-dihydrobenzo[h]quinazolin-2-amine as inhibitors of fibroblast growth factor receptors (... von Ali, Syed M., Brassard, Chris, Dalton, Audra, Kizer, Darin, Lapierre, Jean-Marc, Liu, Yanbin, Moussa, Magdi, Palma, Rocio, Tandon, Manish, Vensel, David, Volckova, Erika, Wang, Jianqiang, Westlund, Neil, Wu, Hui, Yang, Rui-Yang, Bates, Craig, Bhavsar, Mayank, Bull, Cathy, Eathiraj, Sudharshan, Nicewonger, Robert, Savage, Ron, Waghorne, Carol, Castro, Jennifer, Nakuci, Enkeleda, Chen, Chang-Rung, France, Dennis S., Chan, Thomas C.K., Ashwell, Mark A.

Volltext

Abstract 4501: Development and biological annotation of a novel RAF inhibitor amenable for clinical evaluation against BRAF (V600E)-harboring human tumors von Chen, Chang-Rung, Lapierre, Jean-Marc, Szwaya, Jeffrey D., Liu, Yanbin, Namdev, Nivedita, Lowe, Deirdre, Savage, Ron E., Bull, Cathy O., Chan, Thomas C K, Ashwell, Mark A., France, Dennis S.

Volltext

KING OF HANDCUFFS von SAVAGE, RON

Volltext

A New Species of Abronia (Squamata: Anguidae) from a Dry Oak Forest in Eastern Guatemala von Brodie, Edmund D., Ron F. Savage

Volltext

Roles of the Volunteer in Development: Toolkits for Building Capacity von Slater, Marsha, Allsman, Ava, Savage, Ron, Havens, Lani, Blohm, Judee, Raftery, Kate

Volltext bestellen

Nonclassical GH Insensitivity: Characterization of Mild Abnormalities of GH Action von Storr, Helen L, Chatterjee, Sumana, Metherell, Louise A, Foley, Corinne, Rosenfeld, Ron G, Backeljauw, Philippe F, Dauber, Andrew, Savage, Martin O, Hwa, Vivian

Volltext

A high-throughput screen for tuberculosis progression von Carvalho, Ralph, de Sonneville, Jan, Stockhammer, Oliver W, Savage, Nigel D L, Veneman, Wouter J, Ottenhoff, Tom H M, Dirks, Ron P, Meijer, Annemarie H, Spaink, Herman P

Volltext

Revisiting Trade-offs between Rubisco Kinetic Parameters von Flamholz, Avi I, Prywes, Noam, Moran, Uri, Davidi, Dan, Bar-On, Yinon M, Oltrogge, Luke M, Alves, Rui, Savage, David, Milo, Ron

Volltext

Functional reconstitution of a bacterial CO2 concentrating mechanism in Escherichia coli von Flamholz, Avi I, Dugan, Eli, Blikstad, Cecilia, Gleizer, Shmuel, Ben-Nissan, Roee, Amram, Shira, Antonovsky, Niv, Ravishankar, Sumedha, Noor, Elad, Bar-Even, Arren, Milo, Ron, Savage, David F

Volltext

pH determines the energetic efficiency of the cyanobacterial CO₂ concentrating mechanism von Mangan, Niall M., Flamholz, Avi, Hood, Rachel D., Milo, Ron, Savage, David F.

Volltext